Top Markets
Coin of the day
BNC Korea Co., Ltd. BNC Korea Co., Ltd.

BNC Korea Co., Ltd.

256840
Rang in Aktien #21183
Based in South Korea, BNC Korea Co., Ltd. focuses on the research, development,... Based in South Korea, BNC Korea Co., Ltd. focuses on the research, development, manufacturing, and distribution of various biomaterials. The company's diverse product range features hyaluronic acid (HA) and skin booster fillers, including brand names like Cutegel, Cutegel Lidocaine, FLORE Lidocaine, ChungA-an, CUTEGEL-M, Cutegel Hydro, S-DNA, and H-DNA, all designed for the temporary reduction of facial wrinkles through physical restoration. Beyond aesthetic products, BNC Korea also manufactures Hibarry, a specialized dressing for deep-cavity wounds, which helps mitigate spinal cord adhesion during surgery. Another key medical product is GENTA Q, a white collagen sponge created to protect wounds by preventing contamination. Additionally, the company offers a line of beauty solutions, encompassing face mask gels, mild cleansing foams, and brightening peeling gels. With a significant international presence, BNC Korea exports its products to 45 countries. The firm was founded in 2007 and is headquartered in Daegu, South Korea.
Aktienkurs
$1.65
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$113.03M
Veränderung (1 Tag)
-3.63%
Veränderung (1 Jahr)
-52.19%
Land
KR
Handel BNC Korea Co., Ltd. (256840)

Kategorie

EPS für BNC Korea Co., Ltd. (256840)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von BNC Korea Co., Ltd. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von BNC Korea Co., Ltd. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber